A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma
Clinical trial NCT06716853 · TERMINATED
Trial details
- NCT number
- NCT06716853
- Sponsor
- Genenta Science
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2026-01-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.